Department of Pharmacology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Department of Pharmacology, Physiology and Neuroscience, University of South Carolina School of Medicine, Columbia, SC 29208, USA; W.J.B. Dorn VA Medical Center, Columbia, SC 29208, USA.
Neuropharmacology. 2018 Jul 1;136(Pt B):182-191. doi: 10.1016/j.neuropharm.2017.12.001. Epub 2017 Dec 5.
For decades the brain was erroneously considered an insulin insensitive organ. Although gaps in our knowledge base remain, conceptual frameworks are starting to emerge to provide insight into the mechanisms through which insulin facilitates critical brain functions like metabolism, cognition, and motivated behaviors. These diverse physiological and behavioral activities highlight the region-specific activities of insulin in the CNS; that is, there is an anatomical context to the activities of insulin in the CNS. Similarly, there is also a temporal context to the activities of insulin in the CNS. Indeed, brain insulin receptor activity can be conceptualized as a continuum in which insulin promotes neuroplasticity from development into adulthood where it is an integral part of healthy brain function. Unfortunately, brain insulin resistance likely contributes to neuroplasticity deficits in obesity and type 2 diabetes mellitus (T2DM). This neuroplasticity continuum can be conceptualized by the mechanisms through which insulin promotes cognitive function through its actions in brain regions like the hippocampus, as well as the ability of insulin to modulate motivated behaviors through actions in brain regions like the nucleus accumbens and the ventral tegmental area. Thus, the goals of this review are to highlight these anatomical, temporal, and functional contexts of insulin activity in these brain regions, and to identify potentially critical time points along this continuum where the transition from enhancement of neuroplasticity to impairment may take place. This article is part of the Special Issue entitled 'Metabolic Impairment as Risk Factors for Neurodegenerative Disorders.'
几十年来,大脑一直被错误地认为是对胰岛素不敏感的器官。尽管我们的知识库中仍然存在空白,但概念框架开始出现,为我们提供了深入了解胰岛素促进代谢、认知和动机行为等关键大脑功能的机制的见解。这些不同的生理和行为活动突出了胰岛素在中枢神经系统中的区域特异性活动;也就是说,胰岛素在中枢神经系统中的活动具有解剖学背景。同样,胰岛素在中枢神经系统中的活动也具有时间背景。事实上,大脑胰岛素受体的活性可以被概念化为一个连续体,在这个连续体中,胰岛素促进从发育到成年的神经可塑性,它是健康大脑功能的一个组成部分。不幸的是,大脑胰岛素抵抗可能导致肥胖和 2 型糖尿病(T2DM)中的神经可塑性缺陷。这种神经可塑性连续体可以通过胰岛素在海马等脑区促进认知功能的机制,以及胰岛素通过在伏隔核和腹侧被盖区等脑区调节动机行为的能力来进行概念化。因此,本综述的目的是强调这些脑区中胰岛素活动的解剖学、时间和功能背景,并确定沿着这个连续体可能发生从增强神经可塑性到损害的过渡的潜在关键时间点。本文是特刊“代谢障碍作为神经退行性疾病的风险因素”的一部分。